Myopia Profile Sign in Sign in

Eyerising Myopia Management Device

The Eyerising Myopia Management Device delivers Repeated Low-Level Red-Light (RLRL) therapy to the ocular fundus through semi-conductor laser diodes emitting 650nm visible red light. The Eyerising device has been demonstrated to increase choroidal blood flow and induce choroidal thickening, potentially addressing the scleral hypoxia implicated in myopia progression. It is backed by over 40 clinical studies, including 2-year clinical trial results showing myopia control efficacy.

Visit the Eyerising Myopia Management Device website.

Instrument
Eyerising International
Eyerising Myopia Management Device
Myopia control device that delivers repeated low-level red-light (RLRL) to the ocular fundus.
Securely shares patient compliance data with practitioners to monitor efficacy and safe use
 EyeRising Logo_clear background.pngSilver SponsorRed light therapy.pngLight therapies

Eyerising Myopia Management Device.

APAO Showcase: The Latest on Repeated Low-Level Red Light TherapyLight therapiesAPAO Showcase: The Latest on Repeated Low-Level Red Light TherapyThe APAO congress featured the newest research on red light therapy; here, we summarise the evidence. Read full article Real-world cases with red light therapyManaging treatment outcomesReal-world cases with red light therapyFour real-world cases show how repeated low-level red-light (RLRL) therapy can be a powerful tool for myopia management.Read full article Three key myopia questions for 2026 Light therapiesAtropineThree key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read full article Repeated low-level red light and ortho-k combined: first European dataLight therapiesRepeated low-level red light and ortho-k combined: first European dataCombining RLRL with ortho-k slowed eye growth by 0.23 mm in Spanish children, with 80% showing axial shortening after 12 months.Read full article Meta-analysis on RLRL slowing eye growth in myopiaAxial lengthMeta-analysis on RLRL slowing eye growth in myopiaA meta-analysis of 10 randomized controlled trials showed that RLRL therapy slows myopia progression and axial elongation over one year.Read full article Global insights on repeated low-level red light therapy: interview series Myopia control efficacyGlobal insights on repeated low-level red light therapy: interview series A recent interview series with five experts from around the world sheds light on their experiences with RLRL. Read full article Efficacy of repeated low-level red light therapy for high myopia control Light therapiesEfficacy of repeated low-level red light therapy for high myopia control This study found strong efficacy for high myopia and no adverse responses after 1 year of low-level red light therapy use.Read full article Boosting orthokeratology efficacy with repeated low-level red lightOrtho-kLight therapiesBoosting orthokeratology efficacy with repeated low-level red lightThis 1-year study investigated the efficacy and safety of combining orthokeratology and repeated low-level red-light (RLRL) therapyRead full article Can red light therapy delay myopia onset?Pre-myopiaCan red light therapy delay myopia onset?This study found lower myopia incidence and no ocular damage in pre-myopic children using repeated red-light therapy over 12 monthsRead full article Repeated low-level red light therapy: a look at safety and efficacyMyopia control efficacyRepeated low-level red light therapy: a look at safety and efficacyRepeated low-level red light (RLRL) therapy is a new approach to myopia control: read about the research on safety and efficacy. Read full article Repeated low-level red light therapy in the clinic: Q&A with Song Chow, Jagrut Lallu and Simon RoseLight therapiesRepeated low-level red light therapy in the clinic: Q&A with Song Chow, Jagrut Lallu and Simon RoseThree leading eyecare clinicians discuss using repeated low-level red light (RLRL) therapy in their practice. Read full article Follow-up on red-light: safety, efficacy and the rebound effectTreatment safetyFollow-up on red-light: safety, efficacy and the rebound effectRepeated low-level red light therapy is an efficacious myopia control intervention and also carries a rebound effect. Read full article Is red light therapy safe and effective for myopia control?Light therapiesIs red light therapy safe and effective for myopia control?Repeated low-level red light (RLRL) therapy is showing impressive results for myopia control in children, but is it safe? Read more here.Read full article 

Eyerising International resources

Eyerising.png

Eyerising International and Myopia Profile Interview Series: Highlights

Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device.

To watch the interviews in full, please visit
https://www.eyerisinginternational.com/the-device/